Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
- Status
- TERMINATED
- Phase
- PHASE1
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
- Status
- RECRUITING
- Phase
- PHASE2
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
NKG2D CAR-NK & r/rAML
- Status
- UNKNOWN
- Phase
- NA
Drug-screening in AML at Relapse for Targeted Treatment
- Status
- COMPLETED
- Phase
- NA
Psychological Mobile App for Patients With AML
- Status
- TERMINATED
- Phase
- NA
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML
- Status
- UNKNOWN
- Phase
- PHASE1
Universal CAR-γδT Cell Injection in the AML Patients
- Status
- UNKNOWN
- Phase
- NA
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
- Status
- RECRUITING
- Phase
- NA